Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron

Gian Paolo Drago, Ernesto Setti, Lisa Licitra, Diego Liberati

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The integration of chemotherapy and radiotherapy for the treatment of advanced head and neck cancer is still a matter of clinical investigation. An important limitation is that the concomitant administration of chemotherapy and radiotherapy still induces severe toxicity. In this paper, a simple artificial neural network is used to predict, on the basis of biological and clinical data, if the cumulative toxicity of the combined chemo-radiation treatment itself would be tolerated. The resulting method, tested on clinical data from a phase II trial, proved to be able to forecast which patients will tolerate a combined chemo-radiotherapeutic approach. This result should open a new perspective in the clinical approach, by supplying a potential predictive indicator for toxicity.

Original languageEnglish
Pages (from-to)782-787
Number of pages6
JournalIEEE Transactions on Biomedical Engineering
Volume49
Issue number8
DOIs
Publication statusPublished - 2002

Fingerprint

Patient treatment
Toxicity
Chemotherapy
Radiotherapy
Neural networks
Radiation

Keywords

  • Chemo-radiation
  • Head and neck cancer
  • Interval arithmetic
  • Learning
  • Neural networks
  • Perceptrons
  • Performance status
  • Predictive factors
  • Toxicity

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron. / Drago, Gian Paolo; Setti, Ernesto; Licitra, Lisa; Liberati, Diego.

In: IEEE Transactions on Biomedical Engineering, Vol. 49, No. 8, 2002, p. 782-787.

Research output: Contribution to journalArticle

@article{9f47525e33d649eab1c207ba7d3bde58,
title = "Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron",
abstract = "The integration of chemotherapy and radiotherapy for the treatment of advanced head and neck cancer is still a matter of clinical investigation. An important limitation is that the concomitant administration of chemotherapy and radiotherapy still induces severe toxicity. In this paper, a simple artificial neural network is used to predict, on the basis of biological and clinical data, if the cumulative toxicity of the combined chemo-radiation treatment itself would be tolerated. The resulting method, tested on clinical data from a phase II trial, proved to be able to forecast which patients will tolerate a combined chemo-radiotherapeutic approach. This result should open a new perspective in the clinical approach, by supplying a potential predictive indicator for toxicity.",
keywords = "Chemo-radiation, Head and neck cancer, Interval arithmetic, Learning, Neural networks, Perceptrons, Performance status, Predictive factors, Toxicity",
author = "Drago, {Gian Paolo} and Ernesto Setti and Lisa Licitra and Diego Liberati",
year = "2002",
doi = "10.1109/TBME.2002.800788",
language = "English",
volume = "49",
pages = "782--787",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "8",

}

TY - JOUR

T1 - Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptron

AU - Drago, Gian Paolo

AU - Setti, Ernesto

AU - Licitra, Lisa

AU - Liberati, Diego

PY - 2002

Y1 - 2002

N2 - The integration of chemotherapy and radiotherapy for the treatment of advanced head and neck cancer is still a matter of clinical investigation. An important limitation is that the concomitant administration of chemotherapy and radiotherapy still induces severe toxicity. In this paper, a simple artificial neural network is used to predict, on the basis of biological and clinical data, if the cumulative toxicity of the combined chemo-radiation treatment itself would be tolerated. The resulting method, tested on clinical data from a phase II trial, proved to be able to forecast which patients will tolerate a combined chemo-radiotherapeutic approach. This result should open a new perspective in the clinical approach, by supplying a potential predictive indicator for toxicity.

AB - The integration of chemotherapy and radiotherapy for the treatment of advanced head and neck cancer is still a matter of clinical investigation. An important limitation is that the concomitant administration of chemotherapy and radiotherapy still induces severe toxicity. In this paper, a simple artificial neural network is used to predict, on the basis of biological and clinical data, if the cumulative toxicity of the combined chemo-radiation treatment itself would be tolerated. The resulting method, tested on clinical data from a phase II trial, proved to be able to forecast which patients will tolerate a combined chemo-radiotherapeutic approach. This result should open a new perspective in the clinical approach, by supplying a potential predictive indicator for toxicity.

KW - Chemo-radiation

KW - Head and neck cancer

KW - Interval arithmetic

KW - Learning

KW - Neural networks

KW - Perceptrons

KW - Performance status

KW - Predictive factors

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0036071419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036071419&partnerID=8YFLogxK

U2 - 10.1109/TBME.2002.800788

DO - 10.1109/TBME.2002.800788

M3 - Article

C2 - 12148816

AN - SCOPUS:0036071419

VL - 49

SP - 782

EP - 787

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 8

ER -